Cogent Biosciences Inc. (COGT) Statistics & Valuation Metrics - Stocknear

Cogent Biosciences Inc.

NASDAQ: COGT · Real-Time Price · USD
13.10
0.16 (1.24%)
At close: Sep 05, 2025, 11:35 AM

Cogent Biosciences Statistics

Share Statistics

Cogent Biosciences has 139.7M shares outstanding. The number of shares has increased by 4.03% in one year.

139.7M
4.03%
0.01%
99.99%
112.56M
1,766
0.06%

Short Selling Information

The latest short interest is 13.01M, so 9.31% of the outstanding shares have been sold short.

13.01M
9.31%
10.57%
9.22

Valuation Ratios

The PE ratio is -3.17 and the forward PE ratio is -7.19. Cogent Biosciences's PEG ratio is -1.92.

-3.17
-7.19
0
45.2
3.16
-3.89
-1.92
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Cogent Biosciences.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 5.32, with a Debt / Equity ratio of 0.07.

5.32
5.32
0.07
-0.06
-0.08
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.25M
205
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 15.12% in the last 52 weeks. The beta is 0.36, so Cogent Biosciences's price volatility has been higher than the market average.

0.36
15.12%
11.07
8.09
65.37
2,830,343

Income Statement

n/a
-4.4M
-275.94M
-255.86M
-275.94M
-275.94M
-2.46
Full Income Statement

Balance Sheet

The company has 98.17M in cash and 17.47M in debt, giving a net cash position of 80.7M.

98.17M
17.47M
80.7M
-859.48M
274.82M
186.59M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -207.79M and capital expenditures -573K, giving a free cash flow of -208.36M.

-207.79M
-573K
-208.36M
-2.01
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

COGT does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for COGT is $21, which is 62.3% higher than the current price. The consensus rating is "Buy".

$21
62.3%
Buy
10
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Nov 9, 2020. It was a backward split with a ratio of 1:4.

Nov 9, 2020
backward
1:4

Scores

0.61
1